NCT02779530View on ClinicalTrials.gov

CYP4A11 and CYP4F2 Gene Variants as Makers of Cardiovascular Adverse Events of Non-steroidal Anti-inflammatory Drugs

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Drug-Related Side Effects and Adverse Reactions
Interventions
DRUG

Diclofenac

50 mg po, b.i.d for 6 days

OTHER

Placebo

Placebo po, b.i.d. for 6 days

Trial Locations (1)

14048900

Unidade de Pesquisa Clínica HCRP-USP, Ribeirão Preto

All Listed Sponsors
lead

Eduardo Barbosa Coelho

OTHER

NCT02779530 - CYP4A11 and CYP4F2 Gene Variants as Makers of Cardiovascular Adverse Events of Non-steroidal Anti-inflammatory Drugs | Biotech Hunter | Biotech Hunter